Andrew Chia
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Andrew Y. Chia, PharmD, MS, is the Associate Program Director, Regulatory Oncology/Hematology at Genentech, San Francisco area, CA. He has conducted research with his father, John Chia, on enteroviruses and ME/CFS.
Dr Chia developed chronic fatigue syndrome in 1997 while in high school, following a severe respiratory infection and pneumonia. He credits his recovery to the immunomodulator Interferon and the Chinese herb, oxymatrine.[1]
Notable studies[edit | edit source]
- 2015, Functional Dyspepsia and Chronic Gastritis Associated with Enteroviruses[2] (Full Text)
- 2008, Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach[3] (Abstract)
- 2004, Ribavirin and Interferon-α for the Treatment of Patients with Chronic Fatigue Syndrome Associated with Persistent Coxsackievirus B Infection: A Preliminary Observation[4] (Full Text)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
- PubMed | last4
See also[edit | edit source]
Learn more[edit | edit source]
- Dr. John Chia (Infectious Disease Specialist, Torrance, California) - Andrew Chia’s Story by Cort Johnson in Health Rising
References[edit | edit source]
- ↑ "Infectious disease specialist Dr. Chia Treats Chronic Fatigue Syndrome". Health Rising. Retrieved December 13, 2018.
- ↑ Chia, John K.; Chia, Andrew Y.; Wang, David; El-Habbal, Rabiha (2015), "Functional Dyspepsia and Chronic Gastritis Associated with Enteroviruses", Open Journal of Gastroenterology, 5 (4): 21-27., doi:10.4236/ojgas.2015.54005
- ↑ Chia, John; Chia, Andrew (2008). "Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach". Journal of Clinical Pathology. 61 (1): 43–48.
- ↑ Chia, John K; Chia, Andrew (2004). "Ribavirin and Interferon-α for the Treatment of Patients with Chronic Fatigue Syndrome Associated with Persistent Coxsackievirus B Infection: A Preliminary Observation" (PDF). The Journal of Applied Research. 4 (2): 286–292.
